#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
preLekára.sk / Journals / Czech-Slovak Dermatology / 2025 - 1

Hymenoptera Venom Allergy

Czech version

Authors: J. Nemšovská
Authors‘ workplace: Dermatovenerologická klinika LF UK a UNB, Bratislava, prednostka prof. MUDr. Mária Šimaljaková, PhD., MPH, MHA
Published in: Čes-slov Derm, 100, 2025, No. 1, p. 3-12
Category: Reviews (Continuing Medical Education)

Overview

Hymenoptera venom allergy (HVA) is a common cause of anaphylaxis and may be fatal. Diagnosis of the HVA and the identification of the appropriate venom for immunotherapy are based on detailed patient’s medical history, skin tests and detection of sIgE. In unclear cases, the cellular tests are recommended. The management of hymenoptera venom allergy includes short-term interventions to treat acute reactions and long-term strategies to minimize the risk of consecutive reactions. The only treatment to prevent further systemic sting reactions is venom immunotherapy (VIT). There are 2 phases of VIT: the initial build-up phase and the maintenance phase. There are numerous protocols for dose increase during the initial phase of VIT, e. g. the maintenance dose may be reached within one day (ultra-rush), after two to five days (rush) or within weeks or months (cluster, conventional).

Keywords:

venom immunotherapy – hymenoptera venom allergy – allergy diagnosis – rapid protocols

Sources
  1. AKDIS, M., AKDIS, C. A. Therapeutic manipulation of immune tolerance in allergic disease. Nat Rev Drug Discov., 2009, 8, p. 645–660.
  2. ASMUS, K., MEISSNER, M., KAUFMANN, R., VALESKY, E. M. Benefits and limitations of Sting challenge in hymenoptera venom allergy. Allergologie, 2021, 44(2), p. 106–112.
  3. BERGMANN-HUG, K., FRICKER, M., HAUSMANN, O. et al. Sensitization to Hymenoptera venom in pollen allergic patients: frequency and involvement of cross-reacting carbohydrate determinants (CCD). PLoS ONE, 2020, 15(9), e0238740. Dostupné na www: https://doi.org/10.1371/journal.phone.0238740.
  4. BILÓ, M. B., MARTINI, M., PRAVETTONI, V. et al. Large local reactions to Hymenoptera stings: Outcome of restings in real life. Allergy, 2019, p. 1–8. Dostupné na www: https://doi.org/10.1111/all.13863.
  5. BILÓ, M. B., MARTINI, M., TONTINI, C. et al. Anaphylaxis. Eur Ann Allergy Clin Immunol. 2021, 53(1),p. 4–17.
  6. BLANK, S., GROSCH, J., OLLERT, M., BILÓ, M. B. Precision Medicine in Hymenoptera Venom Allergy: Diagnostics, Biomarkers, and Therapy of Different Endotypes and Phenotypes. Front Immunol., 2020, 11, 579409. doi: 10.3389/fimmu.2020.579409.
  7. DE AMICI, M., BARROCI, F., CAIMMI, S. et al. Clinical use of basophil activation test in drug, food and hymenoptera venom allergies. Minerva Pediatr., 2019, 71(2), p. 209–217.
  8. EBERLEIN, B. Basophl Activation as Marker of Clinically Relevant Allergy and Therapy Outcome. Front Immunol., 2020, 11, 1815. doi: 10.3389/fimmu.2020.01815.
  1. FRANCUZIK, W., RUËFF, F., BAUER, A. et al. Phenotype and risk factors of venom-induced anaphylaxis: A case-control study of the European Anaphylaxis Registry. J Allergy Clin Immunol., 2021, 147, 653–662. doi: 10.1016/j.jaci.2020.06.008.
  2. GOLDEN, D. B. K. Update on Insect Sting Anaphylaxis. Curr Allergy Asthma Rep., 2021, 21(3). doi: 10.1007/s11882-021-00998-w.
  3. HEMMINGS, O., KWOK, M., MCKENDRY, R., SANTOS, A. F. Basophil Activation Test: Old and New Applications in Allergy. Curr Allergy Asthma Rep., 2018, 18(12), p. 77.
  4. HOFFMANN, A. F., SANTOS, A. F., MAYORGA, C. et al. The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease. Allergy, 2015, 70, p. 1393–1405.
  5. JAKOB, T., RAFEI-SHAMSABADI, D., SPILLNER, E., MÜLLER, S. Diagnostics in Hymenoptera venom allergy: current concepts and developments with special focus on molecular allergy diagnostics. Allergo J Int., 2017, 26(3), p. 93–105.
  6. KRISHNA, M. T, EWAN, P. W, DIWAKAR, L. et al. Diagnosis and management of hymenoptera venom allergy: British Society for Allergy and Clinical Immunology (BSACI) guidelines. Clin Exp Allergy, 2011, 41, p. 1201–1220.
  7. LYONS, J. J., CHOVANEC, J., O´CONNELL, M. P. et al. Heritable risk for severe anaphylaxis associated with increased α-tryptase-encoding germline copy number at TPSAB1. J Allergy Clin Immunol., 2021, 147, p. 622–632.
  8. MESQUITE, A. M., CARNEIRO-LEÃO, L., AMARAL, L., COIMBRA, A. Hymenoptera Venom Allergy: ReSting reactions. Eur Ann Allergy Clin Immunol., 2021, 53(2), p. 94–96.
  9. MONTEIRO, M. C., ROMÃÉO, P. R., SOARES, A. M. Pharmacological perspectives of wasp venom. Protein Pept Lett., 2009, 16(8), p. 944–952.
  10. MORTASAWI, V., PFUETZNER, W. Diagnosis of insect venom allergy with special considerations for the significance of skin tests. Allergologie, 2021, 44(2), p. 120–130.
  11. MÜLLER, U. R., JOHANSEN, N., PETERSEN, A. B. et al. Hymenoptera venom allergy: analysis of double positivity to honey bee and Vespula venom by estimation of IgE antibodies to species-specific major allergens Api m1 and Ves v5. Allergy, 2009, 64(4), p. 543–548.
  12. NEMŠOVSKÁ, J. Liekové hypersenzitívne reakcie: klasifikácia a patogenéza (1. časť). Čes-slov Derm., 2019, 94(3), p. 99–107.
  13. NIEDOSZYTKO, M., de MONCHY, J., van DOORMAAL, J. J. et al. Masocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy. Allergy, 2009, 64(9), p. 1237–1245.
  14. O´CONNELL, M. P., LYONS, J. J. Hymenoptera venom-induced anaphylaxis and hereditary alpha-tryptasemia. Cur Opin Allergy Clin Immunol., 2020, 20(5), p. 431–437.
  15. PALGAN, K., BARTUZI, Z., GOTZ-ZBIKOWSKA, M. Treatment with a combination of omalizumab and specific immunotherapy for severe anaphylaxis after wasp sting. Int J Immunopathol Pharmacol., 2014, 27(1), p. 109–112.
  16. PASTORELLO, E. A., BORGONOVO, L., PREZIOSI, D. et al. Basal Tryptase High Levels Associated with a History of Arterial Hypertension and Hypercholesterolemia Represent Risk Factors for Severe Anaphylaxis in Hymenoptera Venom-Allergic Subjects over 50 Years Old. Int Arch Allergy Immunol., 2021, 182(2), p. 146–152.
  17. PFŰTZNER, W. Allergen immunotherapy of insect venom allergy: almost 100 years old, but steadily updated. Allergol Select., 2023, 7, p. 211–218.
  18. POSPISHIL, I. M., KAGERER, M., COZZIO, A. et al. Comparison of the Safety Profiles of 3 Different Hymenoptera Venom Immunotherapy Protocols: A Retrospective 2-Center Study of 143 Patients. Int Arch Allergy Immunol., 2020, 181(10), p. 783–789.
  19. POZIOMKOWSKA-GĘSICKA, I., KOSTRZEWSKA, M., KUREK, M. Comorbidities and Cofactors of Anaphylaxis in Patients with Moderate to Severe Anaphylaxis. Analysis of Data from the Anaphylaxis Registry for West Pomerania Province, Poland. Int J Environ Res Public Health., 2021, 18, 333. Dostupné na www: https://doi.org/10.3390/ijerph18010333.
  20. PRZYBILLA. B., RUËFF, F. Hymenoptera venom allergy. J Dtsch Dermatol Ges., 2010, 8, p. 114–129.
  21. PRZYBILLA, B., RUËFF, F., WALKER, A. et al. Diagnose und Therapie der Bienenund Wespengiftallergie. Allergo J., 2011, 20, p. 318–339.
  22. RAHIMIAN, R., SHIRAZI, F. M., SCHMIDT, J. O., KLOTZ, S. A. Honeybee Stings in the Era of Killer Bees: Anaphylaxis and Toxic Envenomation. Am J Med., 2020, 133, p. 621–626.
  23. RING, J., PRZYBILLA, B. J. History of insect venom allergy. Allergologie, 2021, 44(2), p. 132–138.
  24. RING, J., MESSMER, K. Incidence and severity of anaphylactic reactions to colloid volume substitutes. Lancet, 1977, 26, p. 466–469.
  25. RUËFF, F., BAUER, A., BECKER, S. et al. Diagnosis and treatment of Hymenoptera venom allergy. Allergol Select., 2023, 7, p. 154–190.
  26. RUËFF, F., PRZYBILLA, B., FUCHS, T. et al. Diagnose und Therapie der Bienenund Wespengiftallergie. Positionspapier der Deutschen Gesellschaft für Allergologie und klinische Immunologie. Allergo J., 2000, 9, p. 458–472.
  27. RUËFF, F. Natural history and long-term follow-up of Hymenoptera allergy. Curr Opin Allergy Clin Immunol., 2020, 20(5), p. 445–451.
  28. SHAKER, M. S., WALLACE, D. V., GOLDEN D. B. et al. Anaphylaxis-a 2020 practice parameter update, systemic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. Allergy Clin Immunol., 2020, 145(4), p. 1082–1123.
  1. STOEVESANDT, J., STURM, G. J., BONADONNA, P. et al. Risk factors and indicators of severe systemic insect sting reactions. Allergy, 2019, p. 1–11. Dostupné na www: https://doi.org/10.1111/all.13945.
  2. STOCK, R., FISCHER, T., ASMUS, K., ZOELLER, N. et al. Safety and tolerability of venom immunotherapy: Evaluation of 581 rush and ultra-rush induction protocols (safety of rush and ultra-rush venom immunotherapy). World Allergy Organ J., 2020, 14, 100496. Dostupné na www: http://doi. org/10.1016/j.waojou.2020.100496.
  3. STURM, G. J., VARGA, E.-M., ROBERTS, G. et al. EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy. Allergy, 2018, 73, p. 744–764.
  4. TRABADO, A. R., HIJÓN, C. C., CANTARINO, A. R. et al. Short-, Intermediate-, and Long-Term Changes in Basophil Reactivity Induced by Venom Immunotherapy. Allergy Asthma Immunol Res., 2016, 8(5), p. 412–420.
  5. TREUDLER, R., SIMON, J. C. Allergen-specific immunotherapy of hymenoptera allergy: what to consider. Allergologie, 2021, 44(2), p. 113–119.
  6. VALENT, P., AKIN, C., ESCRIBANO, L. et al. Standards and standardisation in mastocytosis: consensus steatments on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest., 2007, 37(6), p. 435–453.

Do redakce došlo dne 15. 12. 2024.

Adresa pro korespondenci:
MUDr. Jana Nemšovská, PhD., MPH, MHA
Dermatovenerologická klinika LF UK a UNB
Mickiewiczova 13
813 69 Bratislava Slovenská republika
e-mail: jana.nemsovska@sm.unb.sk

Labels
Dermatology & STDs Paediatric dermatology & STDs
Registry of Biological/ Targeted Therapy BIOREP – Summary Report 2024
Onychomatricoma: A Rare Tumor of the Nail Matrix. Case Report
Painful Papulopustules and Nodules in the Beard
Zápisnica zo zasadania výboru a dozornej rady Slovenskej dermatovenerologickej spoločnosti
Zápisnica zo zasadania výboru a dozornej rady Slovenskej dermatovenerologickej spoločnosti
Zápis ze schůze výboru ČDS konané dne 17. 10. 2024
Vzpomínka na doc. MUDr. Milana Bučka, CSc.
Odborné akce 2025
Article was published in

Czech-Slovak Dermatology

Issue 1
2025 Issue 1
Popular this week
Most read in this issue
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#